Portal de Periódicos da CAPES

Mast cells, mediators and asthma

1985; Wiley; Volume: 15; Issue: 3 Linguagem: Inglês

10.1111/j.1365-2222.1985.tb02279.x

1365-2222

Stephen T. Holgate, A. B. KAY,

Click Chemistry and Applications

Clinical & Experimental AllergyVolume 15, Issue 3 p. 221-234 Mast cells, mediators and asthma S.T. HOLGATE, S.T. HOLGATESearch for more papers by this authorA. B. KAY, A. B. KAYSearch for more papers by this author S.T. HOLGATE, S.T. HOLGATESearch for more papers by this authorA. B. KAY, A. B. KAYSearch for more papers by this author First published: May 1985 https://doi.org/10.1111/j.1365-2222.1985.tb02279.xCitations: 42AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Porter Porter, J. Bircheds. The identification of asthma, Ciba Foundation Study Group No.38. Edinburgh : Churchill Livingstone. 1971. 2 Hogg JC Parè PD, Boucher R, Michoud. MC, Guerzon G, Moroz L., Pathologic; abnormalities in asthma. In: LM Lichtenstein, KF Austen, eds Asthma physiology, immunopharmacology; and treatment. Vol. 2 New York and London : Academic Press, 1977: 1–14. 3 Laitinen Laitinen, Laitinen L, Heino M, Haahtela T. Bronchial epithelial damage and intraepithelian nerve fibres in asthmatic patients Am Rev Respir Dis (in press). 4 Boulet L.P, Cartier A, Thompson NC, Roberts RS, Dolovich J, Hargreave FE. Asthma and increases in non-allergic bronchial responsiveness from season; pollen exposure. J Allergy Clin Immunol 1983; 74: 399–406. 5 McFadden ER. Pathogenesis of asthma. J Allergy Clin Immunol 1984: 73: 413–24. 6 Gregg I Epidemiological aspects in asthma, 2nd edn TJH Clark, S Godfrey, eds. London Chapman & Hall, 1983: 242–83. 7 Platts-Mills TAE, Tovey E.R, Mitchell EB, Mozarro H, Nock P, Wilkins SR. Reversal of bronchial hyperreactivity during prolonged allergen avoidance Lancet 1982: 2; 675–8. 8 Katz DH. New concepts concerning the clinical control of IgE synthesis. Clin Allergy 1979 9: 609–24. 9 Croner S, Kjellman N-IM, Eriksson B, Roth A. IgE screening in 1701 newborn infants and the development of atopic disease during infancy. Arch Dis Childn 1982; 57: 364–8. 10 Thompson RA, Bird AG. How necessary are specific IgE antibody tests-in allergy diagnosis Lancet 1983, ii: 169–72. 11 Jeffrey P, Corrin B Structural analysis of the respiratory tract J Bienenstock, ed. Immunology of the lung and upper respiratory tract. New York and Toronto : McGraw-Hill. 1984. 12 Caulfield JP, Lewis RA, Hein A, Austen KF. Secretion in dissociated human pulmonary; mast cells. Evidence for solubilization of granule contents before discharge. J Cell Biol 1980; 85: 299–311. 13 Church MK, Pao GJK, Holgate ST Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti -IgE., calcium ionophore A23187. compound 48 80, and basic polypeptides. J Immunol 1982; 129: 2116–21. 14 Metcalfe DD. Effector cell heterogeneity in immediate hypersensitivity reactions. Clin Rev Allergy 1983; 1: 311–25. 15 Miller HRP. The structure, origin and function of mucosal mast cells. A brief review. Biol Cellulaire 1980: 39: 229–32. 16 Razin E, Mencia-Huerta J-M, Stevens RL, Lewis RA, Liu F-T, Corey EJ, Austen KF. IgE mediated release of leukotriene C4. chondroitin sulphate E, β-hexosaminidase. And histamine from cultured bone marrow-derived mouse mast cells. J Exp Med 1983; 157: 189–201. 17 Razin E, Ihle JN, Seldin D, Mencia-Huerta J-M, Katz HR, Leblanc PA, Hein A, Caulfield JP, Austen KF, Stevens RL. Interluekin 3: a differentiation and growth factor for the mouse mast cell that contains chondroitin sulphate E proteoglycan. J Immunol 1984; 132: 1479–86. 18 Lamb D, Lumsden A. Intra-epithelial mast cells in human airway epithelium: evidence for smoking induced changes in their frequency. Thorax 1982; 37: 334–42. 19 Agius RM, Jones D, Holgate ST. Staining characteristics of human pulmanary mast cells Thorax (in press). 20 Agius RM, Knight RK, Godfrey RC, Cole PJ, Holgate ST. Significance of mast cells in bronchoalveolar lavage. Thorax 1984; 39: 708. 21 Tomioka M, Ida S, Yuriko S, Ishihara T, Takishima T Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis 1984; 129: 1000–5. 22 Hastic R, Chir B, Hepog JH, Levy DA Basophil leucocytes and mast cells in human nasal secretions and scrapings studied by light microscopy lab Invest 1979; 40 554–61. 23 Holgate ST, Emanuel MB, Howarth PH. Astemizole and other antihistaminic drug treatment of asthma J Allergy Clin Immunol (suppl) (in press). 24 Kay AB, Lee TH. Neutrophil chemotactic factor of anaphylaxis. J Allergy Clin Immunol 1982; 70: 317–20. 25 Cundell DR, Devalia JL, Davies RJ. Is NCA-chemotactic activity released solely from mast cells Proc Societas European Physiologiae Respiratoriae. Barcelona 1984; (in press). 26 Schwartz LB, Kawahara MS, Hugh TE, Vik D, Fearon DT, Austen KF, Generation of C3a anaphylatoxin from human C3 by mast cell tryptase. J Immunol 1983; 130: 1819–5. 27 Schwartz LB. Tryptase from human pulmonary mast cells. In: AB Kay, KF Austen, LM Lichtenstein, Eds. Asthma physiology, immunopharmacology and treatment London ; Academic Press, 1984: 19–37. 28 Schwartz L.B, Austen KF. Structure and function of the chemical mediators of mast cells. Prog Allergy 1984; 34: 271–321. 29 Metcalf DD, Lewis RA, Silbert JE Rosenberg RW, Wasserman SI, Austen KF. Isolation and characterization of heparin from human lung. J Clin Invest 1979; 64: 1537–42. 30 Lewis RA, Austen KF Mediators of local homeostasis and inflammation by leukotrienes and other mast cell dependent compounds. Nature ( London ) 1981; 293: 103–8. 31 Hardy CC, Robinson C, Tattersfield AE, Holgate ST. The: bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Eng J Med 1984; 311: 209–13. 32 Holgate ST, Burns GB, Robinson C, Church MK Anaphylactic- and calcium-dependent generation of prostaglandin D2: (PGD2:). thromboxane B2, and other cyclooxygenase products of arachidonic acid by dispersed human lung cells and relationship to histamine release. J Immunol 1984: 133: 2138–44. 33 Steel L, Kaliner M, Prostaglandin generating factor of anaphylaxis. Identification and isolation J Biol Chem 1981; 256: 12692–8. 34 Seth RV, Clarke VS, Lewis RA, Tattersfield AE. Effect of propranolol on the airway response to prostaglandin E2: in normal man. Br J Pharmacol 1981: 12: 731–5. 35 Hardy C, Robinson C, Bradding P, Holgate ST Prostacyclin:a functional antagonist of prostaglandin D2-induced bronchoconstriction. Thorax 1984; 39: 646. 36 Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH. Leukotriene B4.a potent chemokinetic and aggregating substance released from polymorphonuelear leukocytes. Nature ( London ) 1980; 286: 264–5. 37 Hammarström S. Leukotrienes. Annu Rev Biochem 1983; 52: 355–77. 38 Goetzl EJ. Oxygenation products of arachidonic acid as mediators of hypersensitivity and inflammation. Med Clin North Am 1981; 65: 809–28. 39 Henson PM, Betz SJ. Neutrophil and platelet interactions in ‘allergic’ and inflammatory reactions: a role for acetyl glyceryl ether phosphorylcholine (platelet activating factor).In: EL Becker, AS Simon, KF Austen, R Alan, eds. Biochemistry of the: acute allergic reactions. Liss. New York : 1981; 51–66. 40 Joseph M, Tonnel A, Torpier G, Capron A, Arnoux B, Benveniste J. Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients. J Clin Invest 1983; 71: 221–30. 41 Marquardt DL, Gruber HE, Wasserman SI. Aenosine release from stimulated mast cells. Proc Natl Acad Sci USA 1984; 81: 6192–6. 42 Londos C, Cooper DMF, Wolff J. Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 1980; 77: 2551–4. 43 Fredholm BB. Release of adenosine from rat lung by antigen and compound 48,80. Acta Physiol Scand 1981: 111: 507–8. 44 Mentzer MR, Rubio R, Bern RM Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am J Physiol 1975; 229: 1625–31. 45 Holgate ST, Mann JS, Cushley MJ. Adenosine as a bronchoconstrictor mediator in asthma and its antagonism by methylxanthines. J Allergy Clin Immunol 1984; 74: 302–6. 46 Kay AB. Eosinophils, In; J Bienenstock, ed. Immunology of the lung and upper respiratory tract Toronto : McGraw-Hill. 1984: 139–56. 47 Filley WV, Holley KE, Kephart GM, Gleich GJ. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissue of patients with bronchial asthma. Lancet 1982; ii: 11–16. 48 Durham SR, Carroll M, Walsh GM, Kay AB. Leukocyte activation in allergen-induced late phase asthmatic reactions. N Eng J Med 1984; 311: 1398–402. 49 Lee TH, Nagakura T, Papageorgiou N, Iikura Y, Kay AB. Exercise-induced late asthmatic reactions with neutrophil chemotactic activity. N Eng J Med 1983: 308: 1502–5. 50 Larsen GL, Shampain MP, Marsh WR, Behrens BL, An animal model of the late asthmatic responses to antigen challenge. In: AB Kay, KF Austen, LM Lichtenstein, eds. Asthma: physiology, immunopharmacology and treatment. London : Academic Press. 1984: 245–62. 51 Durham SR, Lee TH Cromwell O, Shaw RJ, Merrett TG, Merrett J, Cooper P, Kay AB. Immunologic studies in allergen-induced late-phase asthmatic reactions. J Allergy Clin Immunol 1984: 74: 49–60. 52 Blackwell GJ, Carnuccio R, Rosa MD, Flower RJ, Parente I, Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (London) 1980: 287: 147–9. 53 Frank GW, Bevan JA, Electrical stimulation causes endothelium-dependent relaxation of lung vessels. Am J Physiol 1983: 244: 793–8. 54 Diaz P, Galleguillos FR, Gonzalez MC, Pantin C, Kay AB. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate on leukocyte counts, immunoglobulins and complement. J Allergy Clin Immunol 1984; 74: 41–8. 55 Armour CL, Lazar NM, Schellenberg RR, Taylor SM, Chan N, Hogg JC, Parée PD. A comparison of in vivo and in vitro airway reactivity to histamine. Am Rev Respir Dis 1984: 129: 907–10. 56 Szezeklik A. Aspirin and asthma, Eur J Respir Dis 1982; 63: 376–9. 57 Holgate ST, Robinson C. 6,9-deepoxy-6, 9-(phenylimino)-δ6,8-prostaglandin I (U 60257) stimulates prostaglandin D2: and inhibits thromboxane B2: release from ionophore challenged human dispensed lung; cells. Br J Pharmacol 1984: 83: 603–5. 58 Hugli TE The structural basis for anaphylatoxin in chemotactic functions of C3a and C5a In: Critical views in immunology. Boca Raton . Florida : CRC Press. 1981: 321–66. 59 Norn S, Skov PS, Anderson P, Pedersen M, Tonnesen P, Pedersen PS, Moller NE, Hertz J, Hoiy N, Intrinsic asthma and bacterial histamine release. Agents Actions 1982; 12: 101–2. 60 Lee TH, Brown MJ, Causon R, Walport MJ, Kay AB. Exercise-induced release of histamine and neutrophil chemotactic factor in atopic asthmatics. J Allergy Clin Immunol 1982; 77: 73–81. 61 Eggleston PE, Kagey-Sobotka A, Schleimer RP, Lichenstein LM. Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis 1984. 130: 86–91. 62 Holgate ST, Church MK, Cushley MJ, Robinson C, Mann JS, Howarth PH. Pharmacological modulation of airway calibre and mediator release in human models of bronchial asthma. In: AB Kay, KF Austen, LM Lichlenstein, eds. Asthma: physiology, immunopharmacology and treatment. London : Academic Press. 1984: 391–415. 63 Lal S, Malhotra S, Gribben D, Hodder D. Nedocromil sodium: a new drug for the management of bronchial asthma. Thorax 1984: 19: 809–12. 64 Cushley M, Holgate. ST. Theophylline in development of anti-asthma drugs, eds. DR Buckle, H Smith, London : Butterworths. 1984: 205–23. Citing Literature Volume15, Issue3May 1985Pages 221-234 ReferencesRelatedInformation